Tag Archives: ptct

Otonomy Drug Miss, BlackBerry Buyback Lead After Hours Movers

Drug stocks Otonomy (OTIC) and PTC Therapeutics (PTCT) led after-hours movers Thursday, as did teen clothing retailer Aeropostale (ARO) and ailing smartphone maker BlackBerry (BBRY). Otonomy, a clinical-stage biopharmaceutical company that specializes in ear drugs, said that its phase two-B OTO-104 drug trial “narrowly missed” its primary endpoint of reducing Meniere’s disease — a chronic condition that the company says is characterized by acute

PTC Muscular Dystrophy Drug Wins EU Panel Vote

Biotech PTC Therapeutics’ (PTCT) muscular-dystrophy drug got a surprise recommendation from a European Union panel Friday, sending the stock up 50% in early afternoon trading on the stock market. Earlier, the stock rose more than 70%. The Committee for Medicinal Products for Human Use (CHMP), the advisory panel of the European Medicines Agency, recommended conditional approval of PTC’s drug Translarna for patients with Duchenne muscular dystrophy